A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts

scientific article published in August 1986

A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/ARCHPSYC.1986.01800080019003
P698PubMed publication ID3729667

P2093author name stringKosten TR
Kleber HD
Rounsaville BJ
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectopioidQ427523
P1104number of pages6
P304page(s)733-738
P577publication date1986-08-01
P1433published inJAMA PsychiatryQ635830
P1476titleA 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts
P478volume43

Reverse relations

cites work (P2860)
Q3048145030 years of dynorphins--new insights on their functions in neuropsychiatric diseases
Q48700798A path analysis of cognitive, affective, and behavioral predictors of treatment response in a methadone maintenance program
Q34228904A review of temporal effects and outcome predictors in substance abuse treatment studies with long-term follow-ups. Preliminary results and methodological issues
Q36563332A treatment model for craving identification and management
Q24541515Alexithymia and stress-induced brain activation in cocaine-dependent men and women.
Q41337977Background and overview of mental health and substance abuse treatment systems: meeting the needs of women who are pregnant or parenting
Q78700121Behavioral naltrexone therapy: an integrated treatment for opiate dependence
Q45227710Chronic psychosocial stress causes delayed extinction and exacerbates reinstatement of ethanol-induced conditioned place preference in mice
Q40635742Cocaine abuse in methadone maintenance programs: integrating pharmacotherapy with psychosocial interventions
Q34423187Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking.
Q39734970Comorbid depression among untreated illicit opiate users: results from a multisite Canadian study
Q43678227Conditioned fear stimuli reinstate cocaine-induced conditioned place preference.
Q35564245Control Over Stress Accelerates Extinction of Drug Seeking Via Prefrontal Cortical Activation
Q33862344Cost-effectiveness of mental health services for persons with a dual diagnosis: a literature review and the CCMHCP. The Cost-Effectiveness of Community Mental Health Care for Single and Dually Diagnosed Project
Q36894268Counseling Issues in Methadone Maintenance Treatment
Q51003430Depression and hostility as predictors of long-term outcomes among opiate users.
Q39406768Depression as an antecedent of frequency of intravenous drug use in an urban, nontreatment sample
Q48447207Depression in male patients on methadone maintenance therapy
Q43778524Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress re
Q35906594Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review
Q35541534Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review
Q48162637Effects of environmental enrichment on d-amphetamine self-administration following nicotine exposure.
Q44136433Effects of lesions of various brain areas on drug priming or footshock-induced reactivation of extinguished conditioned place preference
Q37012211Effects of major depression on crack use and arrests among women in drug court
Q30468823Emotional arousal and multiple memory systems in the mammalian brain
Q35532072Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
Q51383014Enhanced acquisition of cocaine self-administration in adult rats with neonatal isolation stress experience.
Q42409843Enhanced dendritic availability of μ-opioid receptors in inhibitory neurons of the extended amygdala in mice deficient in the corticotropin-releasing factor-1 receptor
Q40635747Evaluation and treatment of mood and anxiety disorders in opioid-dependent patients
Q52217592Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-administration in rats.
Q48579794Footshock stress reinstates cocaine seeking in rats after extended post-stress delays
Q46547617Heightened cocaine and food self-administration in female rats with neonatal isolation experience
Q34023364Identification of substance use and dependence among patients with viral hepatitis
Q42281009Immobilization stress-induced oral opioid self-administration and withdrawal in rats: role of conditioning factors and the effect of stress on "relapse" to opioid drugs
Q24605833Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine
Q34746998In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine
Q44914221Infusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in rats
Q36907029Is it stress? The role of stress related systems in chronic food restriction-induced augmentation of heroin seeking in the rat
Q24683322Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses
Q43925629Ketoconazole increases cocaine and opioid use in methadone maintained patients
Q43075885Large variation in measures used to assess outcomes of opioid dependence treatment: A systematic review of longitudinal observational studies
Q44653380Lidocaine inactivation of ventral subiculum attenuates cocaine-seeking behavior in rats.
Q44455994Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior
Q36894307Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs)
Q40470835Methadone maintenance treatment: An update
Q30455336Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence
Q36932596Norepinephrine at the nexus of arousal, motivation and relapse
Q34971483On beyond urine: clinically useful assessment instruments in the treatment of drug dependence.
Q26778626Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria
Q39221067Oxytocin and opioid addiction revisited: old drug, new applications.
Q37830040Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence
Q36139937Pilot study of treatment for major depression among women prisoners with substance use disorder
Q44350042Predictors of 2.5-year outcome in opioid addicts: pretreatment source of income
Q44333559Prevalence and predictors of psychopathology among opioid users
Q28569725Prior exposure to chronic stress and MDMA potentiates mesoaccumbens dopamine release mediated by the 5-HT(1B) receptor
Q51769845Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan.
Q52275542Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program.
Q34428032Resolving problems associated with alcohol and drug misuse: understanding relations between addictive behavior change and the use of services
Q33847097Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats
Q48621946Social defeat stress, sensitization, and intravenous cocaine self-administration in mice
Q34459334Stimulation of α2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats
Q35080432Stress and relapse to drug seeking: studies in laboratory animals shed light on mechanisms and sources of long-term vulnerability
Q42277951Stress reinstates heroin-seeking in drug-free animals: An effect mimicking heroin, not withdrawal
Q30366964Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.
Q48201478Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat.
Q74248968Stress-induced relapse to heroin and cocaine seeking in rats: a review
Q41295451Suicidality among opioid addicts: 2.5 year follow-up
Q44760826Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids
Q36950663Tetrodotoxin reduces cue-induced drug craving and anxiety in abstinent heroin addicts
Q43767374The allocation of drug addicts to different types of treatment. An evaluation and a two-year follow-up
Q33573725The association between social stressors and drug use/hazardous drinking among former prison inmates
Q41127953The management of treatment resistance in depressed patients with substance use disorders
Q34178687The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review
Q47892402The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats.
Q45017073The role of prefrontal cortex D1-like and D2-like receptors in cocaine-seeking behavior in rats
Q41742771The role of stress in drug self-administration
Q36813086Unidirectionality Between Borderline Personality Disorder Traits and Psychopathology in a Residential Addictions Sample: A Short-Term Longitudinal Study
Q40931192What is the psychiatrist's role in drugs and alcohol?
Q33819245mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse
Q33959173“I know if I drink I won’t feel anything”: substance use relapse among depressed women leaving prison

Search more.